Mission: Building upon the collective strength of the vasculitis community, the VF inspires and empowers individuals with vasculitis and their families through a wide range of education, research, clinical, and awareness initiatives.
VF Dream Big Educational Webinar Series 2018
Topic: Pregnancy and Family Planning Concerns of Women with Vasculitis
Guest Speaker: Megan Clowse, MD, MPH, Duke University Hospital
Date: Tuesday, April 24, 2018
Time: 6:00 p.m. Eastern
Register:
The V-PPRN seeks to transform how clinical research in vasculitis is conducted by directly engaging patients, investigators, care providers, and health systems to develop research methods to electronically collect health records and patient-reported data on a large number of patients with various forms of vasculitis.
The VF Board of Directors is pleased to announce it has selected three new research studies for funding in 2018. The studies were chosen from a selection of 20 applications more »
GlaxoSmithKline (GSK) achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US December 13, 2017: GSK announced that the US Food and more »
#GivingTuesday is a global day of giving fueled by the power of social media and collaboration. This year your donation can go even further with our generous matching gift challenge! more »
Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship. She received her medical degree from New York Medical College in Valhalla, New York. She completed her Internal Medicine more »
Brandon Hudgins, professional long-distance runner, GPA/Wegener’s patient and leader of VF Team Brandon, has shared his story in his recently released book, “Going the Distance: The Journey of a Vasculitis more »
Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »